RACK1 and neoplasm: Furthermore, O‐GlcNAcylation of RACK1 has been shown to promote tumour development, with elevated RACK1 O‐GlcNAcylation levels detected in hepatocellular carcinoma patient liver samples, correlating with tumour proliferation and recurrence.13